Researchers from Kyoto University’s Centre for iPS Cell Research and Application in Japan are making strides towards the world’s first application of induced Pluripotent Stem Cells (iPSCs) to treat Parkinson’s disease.
Characterized by tremors, muscular rigidity, and slow, imprecise movement, Parkinson’s disease is a progressive neurological condition and can worsen over time.
In the study, researchers will take iPSCs from healthy subjects, find patients that match with the cells, then induce the cells to become dopaminergic progenitors. Once the process is complete, the dopaminergic progenitors will then be injected into the regions that are known to play a major role in neural degeneration and are linked with Parkinson’s disease called the “putamen.”
One is that with Regenerative Medicine in NV, patients can potentially receive longer-term treatments for the disease. As of now, patients diagnosed with Parkinson’s disease take oral dopamine medications, but their benefits start to disappear after about a decade of taking.
Lastly, PRP Therapy in Las Vegas, NV can also greatly improve the motor functions of patients with Parkinson’s disease.
For more details about stem cell therapy and treatment, you may contact the Regenerative Cell Institute. We’d be more than happy to address any of your concerns!